Report Code: TIPRE00003491 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Inflammatory bowel disease (IBD) is a term which is used to describe the disorders that involve chronic inflammation of the digestive tract. The two types of IBD include namely, ulcerative colitis and crohn's disease that usually involve severe diarrhea, abdominal pain, fatigue and weight loss. The treatment of the IBD is to reduce the inflammation that triggers your signs and symptoms. The treatment involve the drug therapy or surgery. Drugs therapy include, Anti-inflammatory drugs that further include corticosteroids and aminosalicylates such as, mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum), depending upon the affected area of colon.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The inflammatory bowel disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the inflammatory bowel disease treatment market in these regions.
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 Pandemic has increased the demand inflammatory bowel disease treatment across the globe.
Owing to the COVID 19 situation, there were many of the companies focused on the development of the effective vaccines, biologics and drugs to prevent/cure the disease. However, due to the slowdown of development and manufacturing of other pharmaceuticals or biologics coupled with supply chain disruption, the market has witnessed difficulties in 2020. Further, due to the several limitations of the lockdown, cares for children with IBD have been kept to minimal standards, giving priorities to the urgencies and to biologics' infusions and implementing telemedicine services.
The report covers key developments in the inflammatory bowel disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from inflammatory bowel disease treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for inflammatory bowel disease treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the inflammatory bowel disease treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.